BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

409 related articles for article (PubMed ID: 26479420)

  • 21. Evaluation of AJCC tumor staging for cutaneous squamous cell carcinoma and a proposed alternative tumor staging system.
    Jambusaria-Pahlajani A; Kanetsky PA; Karia PS; Hwang WT; Gelfand JM; Whalen FM; Elenitsas R; Xu X; Schmults CD
    JAMA Dermatol; 2013 Apr; 149(4):402-10. PubMed ID: 23325457
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diagnosis and treatment of invasive squamous cell carcinoma of the skin: European consensus-based interdisciplinary guideline.
    Stratigos A; Garbe C; Lebbe C; Malvehy J; del Marmol V; Pehamberger H; Peris K; Becker JC; Zalaudek I; Saiag P; Middleton MR; Bastholt L; Testori A; Grob JJ; ; ;
    Eur J Cancer; 2015 Sep; 51(14):1989-2007. PubMed ID: 26219687
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comprehensive genomic profiling of inflammatory breast cancer cases reveals a high frequency of clinically relevant genomic alterations.
    Ross JS; Ali SM; Wang K; Khaira D; Palma NA; Chmielecki J; Palmer GA; Morosini D; Elvin JA; Fernandez SV; Miller VA; Stephens PJ; Cristofanilli M
    Breast Cancer Res Treat; 2015 Nov; 154(1):155-62. PubMed ID: 26458824
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High-risk cutaneous squamous cell carcinoma.
    Nuño-González A; Vicente-Martín FJ; Pinedo-Moraleda F; López-Estebaranz JL
    Actas Dermosifiliogr; 2012 Sep; 103(7):567-78. PubMed ID: 22261673
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Integrating gene expression profiling into NCCN high-risk cutaneous squamous cell carcinoma management recommendations: impact on patient management.
    Farberg AS; Hall MA; Douglas L; Covington KR; Kurley SJ; Cook RW; Dinehart SM
    Curr Med Res Opin; 2020 Aug; 36(8):1301-1307. PubMed ID: 32351136
    [No Abstract]   [Full Text] [Related]  

  • 26. Comprehensive genomic profiling of epithelial ovarian cancer by next generation sequencing-based diagnostic assay reveals new routes to targeted therapies.
    Ross JS; Ali SM; Wang K; Palmer G; Yelensky R; Lipson D; Miller VA; Zajchowski D; Shawver LK; Stephens PJ
    Gynecol Oncol; 2013 Sep; 130(3):554-9. PubMed ID: 23791828
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MicroRNA-203 Inversely Correlates with Differentiation Grade, Targets c-MYC, and Functions as a Tumor Suppressor in cSCC.
    Lohcharoenkal W; Harada M; Lovén J; Meisgen F; Landén NX; Zhang L; Lapins J; Mahapatra KD; Shi H; Nissinen L; Kähäri VM; Ståhle M; Sonkoly E; Grandér D; Arsenian-Henriksson M; Pivarcsi A
    J Invest Dermatol; 2016 Dec; 136(12):2485-2494. PubMed ID: 27452220
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Upregulation of LINC00319 indicates a poor prognosis and promotes cell proliferation and invasion in cutaneous squamous cell carcinoma.
    Li F; Liao J; Duan X; He Y; Liao Y
    J Cell Biochem; 2018 Dec; 119(12):10393-10405. PubMed ID: 30145798
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epithelial and stromal syndecan-1 and -2 are distinctly expressed in oral- and cutaneous squamous cell carcinomas.
    Ahmed Haji Omar A; Haglund C; Virolainen S; Häyry V; Atula T; Kontio R; Rihtniemi J; Pihakari A; Salo T; Hagström J; Sorsa T
    J Oral Pathol Med; 2013 May; 42(5):389-95. PubMed ID: 23278563
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Circular RNA expression in cutaneous squamous cell carcinoma.
    Sand M; Bechara FG; Gambichler T; Sand D; Bromba M; Hahn SA; Stockfleth E; Hessam S
    J Dermatol Sci; 2016 Sep; 83(3):210-8. PubMed ID: 27298156
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk factors and timing of subsequent cutaneous squamous cell carcinoma in patients with cutaneous squamous cell carcinoma: A retrospective cohort study.
    Rodriguez M; Beal BT; Manmohan M; Simmons E; Varra V; Xiong D; Eversman A; Briskin IN; Knackstedt T; Vidimos AT
    J Am Acad Dermatol; 2021 Mar; 84(3):719-724. PubMed ID: 32861709
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gene methylation in gastric cancer.
    Qu Y; Dang S; Hou P
    Clin Chim Acta; 2013 Sep; 424():53-65. PubMed ID: 23669186
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tumor cell-specific AIM2 regulates growth and invasion of cutaneous squamous cell carcinoma.
    Farshchian M; Nissinen L; Siljamäki E; Riihilä P; Piipponen M; Kivisaari A; Kallajoki M; Grénman R; Peltonen J; Peltonen S; Quint KD; Bavinck JNB; Kähäri VM
    Oncotarget; 2017 Jul; 8(28):45825-45836. PubMed ID: 28526809
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Integrative mRNA profiling comparing cultured primary cells with clinical samples reveals PLK1 and C20orf20 as therapeutic targets in cutaneous squamous cell carcinoma.
    Watt SA; Pourreyron C; Purdie K; Hogan C; Cole CL; Foster N; Pratt N; Bourdon JC; Appleyard V; Murray K; Thompson AM; Mao X; Mein C; Bruckner-Tuderman L; Evans A; McGrath JA; Proby CM; Foerster J; Leigh IM; South AP
    Oncogene; 2011 Nov; 30(46):4666-77. PubMed ID: 21602893
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comprehensive genomic profiling of extrahepatic cholangiocarcinoma reveals a long tail of therapeutic targets.
    Lee H; Wang K; Johnson A; Jones DM; Ali SM; Elvin JA; Yelensky R; Lipson D; Miller VA; Stephens PJ; Javle M; Ross JS
    J Clin Pathol; 2016 May; 69(5):403-8. PubMed ID: 26500333
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Overexpression and Implications of Melanoma-associated Antigen A12 in Pathogenesis of Human Cutaneous Squamous Cell Carcinoma.
    Zhao G; Bae JY; Zheng Z; Park HS; Chung KY; Roh MR; Jin Z
    Anticancer Res; 2019 Apr; 39(4):1849-1857. PubMed ID: 30952725
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genomic Profiling of Penile Squamous Cell Carcinoma Reveals New Opportunities for Targeted Therapy.
    McDaniel AS; Hovelson DH; Cani AK; Liu CJ; Zhai Y; Zhang Y; Weizer AZ; Mehra R; Feng FY; Alva AS; Morgan TM; Montgomery JS; Siddiqui J; Sadis S; Bandla S; Williams PD; Cho KR; Rhodes DR; Tomlins SA
    Cancer Res; 2015 Dec; 75(24):5219-27. PubMed ID: 26670561
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epidermal growth factor receptor expression is associated with poor outcome in cutaneous squamous cell carcinoma.
    Cañueto J; Cardeñoso E; García JL; Santos-Briz Á; Castellanos-Martín A; Fernández-López E; Blanco Gómez A; Pérez-Losada J; Román-Curto C
    Br J Dermatol; 2017 May; 176(5):1279-1287. PubMed ID: 27510450
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cutaneous squamous cell carcinoma staging may influence management in users: A survey study.
    Patel VA; McCullum C; Sparks AD; Schmults CD; Arron ST; Jambusaria-Pahlajani A
    Cancer Med; 2022 Jan; 11(1):94-103. PubMed ID: 34796670
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeted deep sequencing reveals genomic alterations of actinic keratosis/cutaneous squamous cell carcinoma in situ and cutaneous squamous cell carcinoma.
    Kim YS; Jung SH; Park YM; Park GS; Kim HS; Maeng LS; Chung YJ
    Exp Dermatol; 2023 Apr; 32(4):447-456. PubMed ID: 36533870
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.